Novus Light Home



Bruker Corporation recently announced the acquisition of two optical companies.

The company acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems, an acquisition that fills a gap in the technology and product portfolio of the Bruker BioSpin Preclinical Imaging (PCI) division, broadening its range of preclinical solutions for disease research.

Established in 2009 in Tucson, Spectral Instruments Imaging (SII) is at the forefront of technology for co-registered bioluminescence (BLI), fluorescence (FLI), and X-ray preclinical imaging. SII systems are engineered with advanced optics, patented illumination, -90o C air-cooled high sensitivity cameras, absolute calibration for quantifiable imaging, excellent flexibility and ease of use.

The SII flagship system Lago X is designed for superior sensitivity and high-volume in-vivo imaging research. The SII high-efficiency AMI HTX system permits BLI, FLI and X-ray imaging with a benchtop system. SII Aura software provides a seamless workflow for enhanced productivity.

Financial details of the transaction were not disclosed. In 2023, SII generated revenues of over $10 million and was profitable.

Bruker also acquired Nanophoton Corporation, a pioneer focused on advanced research Raman microscopy systems. Headquartered in Osaka, Japan, Nanophoton offers a broad portfolio of advanced Raman microscopes, serving academic and industrial research customers, primarily in Japan. This acquisition fills a gap in Bruker’s molecular microscopy portfolio, and Bruker is looking forward to offering fast, flexible and sensitive Nanophoton Raman microscopy systems worldwide for research and development in the life sciences, biopharma, advanced materials, semiconductors and polymers.

Nanophoton augments the molecular microscopy portfolio of the Bruker Optics division with a broad range of state-of-the-art Raman microscopy systems, which offer exceptional speed, sensitivity and spatial resolution, combined with user-friendly workflows designed for outstanding user experience. The applications include inspecting advanced semiconductor and nanomaterials, batteries, organic and liquid-crystal displays, nanocarbon materials, identifying organic components, mapping the distribution of active pharmaceutical ingredients and excipients in tablets, and clinical research on disease patterns in tissues.

Financial terms of the transaction were not disclosed. In 2023, Nanophoton Corporation had revenues of approximately $5 million, and was near break-even.

Labels: Bruker,Nanophoton,Spectral Instruments,optics

Back Back to News

Illuminating Products

Copyright © 2024 Novus Media Today Group, LLC. All rights reserved. Website design and build by MM Design.